Retinal vessel analyzer measurements of the effect of panretinal photocoagulation on the retinal arteriolar diameter in diabetic retinopathy
- PMID: 20010452
- DOI: 10.1097/IAE.0b013e3181bd2f79
Retinal vessel analyzer measurements of the effect of panretinal photocoagulation on the retinal arteriolar diameter in diabetic retinopathy
Abstract
Purpose: The purpose of this study was to investigate the effect of panretinal photocoagulation (PRP) on the retinal arteriolar diameter in patients with diabetic retinopathy using a retinal vessel analyzer.
Methods: Ten eyes of 6 consecutive patients with type II diabetes and severe nonproliferative or proliferative diabetic retinopathy were studied prospectively. Measurements of the retinal arteriolar diameter were performed before the first photocoagulation session and after the end of the PRP treatment.
Results: Retinal arteriolar diameter before PRP was 131 +/- 15 arbitrary units and decreased to 112 +/- 14 arbitrary units after PRP (P = 0.012). There was a significant vasoconstriction of 13.8% +/- 8.3% following PRP. Mean visual acuity before and after PRP was 0.31 +/- 0.36 logarithm of the minimal angle of resolution and 0.28 +/- 0.30 logarithm of the minimal angle of resolution, respectively (P = 0.68). There was no significant change in mean arterial pressure before and after PRP (P = 0.89). There was no correlation between the visual acuity change or the number of laser burns and the percentage change in the retinal arteriolar diameter (P > 0.1).
Conclusion: Panretinal photocoagulation has a vasoconstrictive effect on retinal arterioles in patients with severe nonproliferative or proliferative diabetic retinopathy. These results are consistent with an autoregulatory response of the retinal circulation to increased inner retinal oxygen tension after PRP. The retinal vessel analyzer is a fast, accurate, noninvasive, online measuring system for the study of the retinal vascular response to PRP in patients with diabetic retinopathy.
Similar articles
-
Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.Ophthalmology. 2006 Mar;113(3):381-7. doi: 10.1016/j.ophtha.2005.10.035. Epub 2006 Feb 3. Ophthalmology. 2006. PMID: 16458970 Clinical Trial.
-
Effect of panretinal photocoagulation on choroidal circulation in the foveal region in patients with severe diabetic retinopathy.Br J Ophthalmol. 2008 Oct;92(10):1369-73. doi: 10.1136/bjo.2007.136028. Epub 2008 Jul 28. Br J Ophthalmol. 2008. PMID: 18662912
-
Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.Retina. 2010 Feb;30(2):254-9. doi: 10.1097/IAE.0b013e3181b4f125. Retina. 2010. PMID: 20057344 Clinical Trial.
-
The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.Ophthalmic Surg. 1980 Apr;11(4):235-45. Ophthalmic Surg. 1980. PMID: 6155650 Review.
-
Panretinal photocoagulation for proliferative diabetic retinopathy.N Engl J Med. 2011 Oct 20;365(16):1520-6. doi: 10.1056/NEJMct0908432. N Engl J Med. 2011. PMID: 22010918 Review. No abstract available.
Cited by
-
Diabetic Macular Edema: From Old Concepts to New Therapeutic Avenues.Med Hypothesis Discov Innov Ophthalmol. 2015 Winter;4(4):130-135. Med Hypothesis Discov Innov Ophthalmol. 2015. PMID: 27800500 Free PMC article. Review.
-
Statistical Model of Optical Coherence Tomography Angiography Parameters That Correlate With Severity of Diabetic Retinopathy.Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4292-4298. doi: 10.1167/iovs.18-24142. Invest Ophthalmol Vis Sci. 2018. PMID: 30167660 Free PMC article.
-
Clinically Significant Nonperfusion Areas on Widefield OCT Angiography in Diabetic Retinopathy.Ophthalmol Sci. 2022 Nov 2;3(1):100241. doi: 10.1016/j.xops.2022.100241. eCollection 2023 Mar. Ophthalmol Sci. 2022. PMID: 36545265 Free PMC article.
-
Effect of panretinal photocoagulation versus intravitreal bevacizumab injection on optic disc microcirculation in patients with diabetic retinopathy.Int J Retina Vitreous. 2024 Dec 18;10(1):98. doi: 10.1186/s40942-024-00621-w. Int J Retina Vitreous. 2024. PMID: 39695775 Free PMC article.
-
Optic nerve head perfusion changes in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab or photocoagulation: a randomized controlled trial.Med Hypothesis Discov Innov Ophthalmol. 2023 Feb 3;11(4):144-150. doi: 10.51329/mehdiophthal1459. eCollection 2022 Winter. Med Hypothesis Discov Innov Ophthalmol. 2023. PMID: 37641606 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials